$11.42
0.131.15%
Last update: Aug 24, 3:12 PM
Fennec Pharmaceuticals Inc Earnings Estimates
FENCNASDAQ
Fennec Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:FENC
Fennec Pharmaceuticals (FENC) is scheduled to report Q3 earnings on November 12, 2026. Analysts estimate EPS of $0.11 and quarterly revenue of $18.59M.
In the most recent quarter (Q2), Fennec Pharmaceuticals reported EPS of $0.05, beating estimates of $0.02 by 1.5%. Revenue came in at $17.87M, exceeding the estimate of $16.09M by 0.11%.
Fennec Pharmaceuticals has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Fennec Pharmaceuticals has averaged an EPS surprise of 2.21% and a revenue surprise of 0.1%.
Earnings Date
Nov 12
EPS Estimate
$0.110
Quarterly Revenue Estimate
$18.59M
Annual Revenue
$59.22M
as of Jun 30
Fennec Pharmaceuticals Earnings History
Analyze the earnings history of Fennec Pharmaceuticals using advanced sorting and filters.
Fennec Pharmaceuticals (FENC) Earnings Per Share
The chart below shows Fennec Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Fennec Pharmaceuticals (FENC) Revenue
The chart below shows Fennec Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Fennec Pharmaceuticals (NASDAQ:FENC) reporting earnings?
Fennec Pharmaceuticals (FENC) is scheduled to report earnings on November 12, 2026. The last reported earnings were for reported on August 11, 2026 for Q2.
What were the latest earnings per share (EPS) for Fennec Pharmaceuticals (NASDAQ:FENC)?
The Actual EPS was $0.05, which beat the estimate of $0.02.
What were Fennec Pharmaceuticals’s (NASDAQ:FENC) revenues?
The Actual Revenue was $17.87M, which beat the estimate of $16.09M.
